Inicio › Adenocarcinoma de esófago › Pensilvania
Ensayos clínicos de Adenocarcinoma de esófago en Pensilvania
15 estudios sobre Adenocarcinoma de esófago buscan participantes en Pensilvania.
Ciudades en Pensilvania
Texto oficial del estudio (inglés)
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
- Lehigh Valley Hospital-Cedar Crest, Allentown
- UPMC-Heritage Valley Health System Beaver, Beaver
- Lehigh Valley Hospital - Muhlenberg, Bethlehem
- y 24 más
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 oct 2026 · NCT06203600mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
- Lehigh Valley Hospital-Cedar Crest, Allentown
- Lehigh Valley Hospital - Muhlenberg, Bethlehem
- Christiana Care Health System-Concord Health Center, Chadds Ford
- y 14 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT05677490A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
- UPMC Hillman Cancer Center, Pittsburgh
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 30 sept 2026 · NCT07221149Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- Penn State Milton S. Hershey Medical Center, Hershey
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 30 sept 2026 · NCT06324357Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
- Alliance Cancer Specialists, PC, Bensalem
- Alliance Cancer Specialists, PC, Doylestown
- Alliance Cancer Specialists, PC, Horsham
- y 4 más
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT07392892A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- Sidney Kimmel Comprehensive Cancer Center Thomas Jefferson University, Philadelphia
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT07277413Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
- University of Pennsylania, Perelman School of Medicine, Philadelphia
- University of Pittsburgh Medical Center, Pittsburgh
Reclutando
Edades de 18 a 89 · Todos los sexos · Actualizado el 11 sept 2026 · NCT05753748Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
- Research Site, Hershey
- Research Site, Philadelphia
- Research Site, Pittsburgh
- y 3 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 sept 2026 · NCT07431281A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
- Normunity Investigational Site, Philadelphia
- Normunity Investigational Site, Philadelphia
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 18 ago 2026 · NCT07182149A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
- University of Pittsburg Medical Center _UPMC Hillman Cancer Center, Pittsburgh
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 15 jul 2026 · NCT06657144Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance
- Geisinger Medical Center, Danville
Reclutando
Edades de 18 a 89 · Todos los sexos · Actualizado el 1 jul 2026 · NCT05530343Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies
- UPMC Hillman Cancer Center, Pittsburgh
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 23 jun 2026 · NCT04114136Study of Suratadenoturev (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 23 abr 2026 · NCT06340711Patient Preference for Subcutaneous vs. Intravenous Immune Therapy
- UPMC Hillman Cancer Center, Pittsburgh
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 16 abr 2026 · NCT07223424Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies
- UPMC Hillman Cancer Center, Pittsburgh
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 21 ene 2026 · NCT03539822De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.